Creative Planning Oyster Point Pharma, Inc. Transaction History

Creative Planning

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$7.95 - $11.68 $7,950 - $11,680	1,000 Added 0.94%	107,662 $1.2 Million
Q1 2022 May 16, 2022	BUY	$8.58 - $17.65 $56,911 - $117,072	6,633 Added 6.63%	106,662 $1.24 Million
Q4 2021 Feb 11, 2022	BUY	$10.17 - $18.96 $314,822 - $586,925	30,956 Added 44.82%	100,029 $1.83 Million
Q4 2020 Jan 29, 2021	BUY	$18.13 - $25.18 $1.25 Million - $1.74 Million	69,073 New	69,073 $1.3 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.